Bisphosphonates and Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

被引:0
|
作者
Gregor, M. Chavez-Mac [1 ]
Brown, E. N. [1 ]
Lei, X. [1 ]
Hsu, L. [1 ]
Meric-Bernstam, F. [1 ]
Litton, J. [1 ]
Mittendorf, E. A. [1 ]
Valero, V. [1 ]
Hortobagyi, G. N. [1 ]
Gonzalez-Angulo, A. M. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1158/0008-5472.SABCS10-P1-11-22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-11-22
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer
    Chavez-MacGregor, Mariana
    Brown, Erika
    Lei, Xiudong
    Litton, Jennifer
    Meric-Bernstram, Funda
    Mettendorf, Elizabeth
    Hernandez, Leonel
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana Maria
    CANCER, 2012, 118 (02) : 326 - 332
  • [2] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Mueller, Carolin
    Schmidt, Gilda
    Juhasz-Boess, Ingolf
    Jung, Lisa
    Huwer, Sarah
    Solomayer, Erich-Franz
    Juhasz-Boess, Stephanie
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1065 - 1071
  • [3] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Carolin Müller
    Gilda Schmidt
    Ingolf Juhasz-Böss
    Lisa Jung
    Sarah Huwer
    Erich-Franz Solomayer
    Stephanie Juhasz-Böss
    Archives of Gynecology and Obstetrics, 2021, 304 : 1065 - 1071
  • [4] Parsing Pathologic Complete Response in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer
    Morrow, Monica
    JAMA ONCOLOGY, 2016, 2 (04) : 516 - 517
  • [5] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    M Tanioka
    C Shimizu
    K Yonemori
    K Yoshimura
    K Tamura
    T Kouno
    M Ando
    N Katsumata
    H Tsuda
    T Kinoshita
    Y Fujiwara
    British Journal of Cancer, 2010, 103 : 297 - 302
  • [6] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    Tanioka, M.
    Shimizu, C.
    Yonemori, K.
    Yoshimura, K.
    Tamura, K.
    Kouno, T.
    Ando, M.
    Katsumata, N.
    Tsuda, H.
    Kinoshita, T.
    Fujiwara, Y.
    BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 297 - 302
  • [7] Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian Bill
    Krishnamurti, Uma
    Bhattarai, Shristi
    Ktimov, Sergey
    Reid, Michelle D.
    O'Regan, Ruth
    Aneja, Ritu
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (06) : 871 - 878
  • [8] Clinical and pathologic predictors of complete pathologic response to neoadjuvant docetaxel/anthracycline chemotherapy in breast cancer patients.
    Coplin, M
    Naughton, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 85S - 85S
  • [9] Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response
    Li, Xianjun
    Liu, Yang
    Shan, Ming
    Xu, Biagqi
    Lu, Yubo
    Zhang, Guoqiang
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (02) : 1205 - 1214
  • [10] Survival and recurrence of breast cancer patients with pathologic complete response after neoadjuvant chemotherapy.
    Lee, Young Joo
    Ahn, Sei-Hyun
    Sohn, Byung Ho
    Lee, Jong Won
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Kim, Jisun
    Lee, Sae Byul
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)